Skip to main content

Table 1 Participants’ sociodemographic characteristics

From: Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation

Characteristics

TOTAL N = 48

Think Tank 1 (n = 16)

Think Tank 2 (n = 15)

Think Tank 3 (n = 17)

Type of participants

 Patient/Family Membera

18

6

5

7

 Researcher (clinical or non-clinical)

7

5

1

1

 Health Care Professional

7

1

4

2

 Multiple Rolesb

16

4

5

7

Country of Residence (continent)c

 Europe

31

10

10

11

 North America

11

3

3

5

 Otherd

6

3

2

1

Gender

 Female

33

11

10

12

 Male

15

5

5

5

Education

 PhD

13

6

4

3

 MA/MSc

13

3

2

8

 Bachelor/High School

22

7

9

6

Experience CDG (Years)

 <5

22

7

6

9

 5–9

12

4

4

4

 ≥ 10

14

5

5

4

Involvement in patient organisation

 Yes

24

6

7

11

 No

24

10

8

6

  1. aIt includes 1 patient and 17 family members
  2. bIt includes participants with more than one role: family member and non-clinical researcher (n = 1); family member and health care professional (n = 4); clinical researcher and health care professional (n = 8); family member, clinical researcher and health care professional (n = 3)
  3. cIt includes the following countries: Australia, Belgium, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Netherlands, Slovak Republic, Spain, Sweden, Turkey, UK, USA, and United Arab Emirates
  4. dIt includes participants from Asia (n = 2), Australia (n = 2) and South America (n = 2)